Cargando…

Development and Verification of an Immune-Based Gene Signature for Risk Stratification and Immunotherapeutic Efficacy Assessment in Gastric Cancer

OBJECTIVE: Due to the molecular heterogeneity of gastric cancer, only minor patients respond to immunotherapeutic schemes. This study is aimed at developing an immune-based gene signature for risk stratification and immunotherapeutic efficacy assessment in gastric cancer. METHODS: An immune-based ge...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiu, Feng, Zhu, Yumei, Shi, Yafeng, Ji, Jingjing, Jin, Yingchao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8602949/ https://www.ncbi.nlm.nih.gov/pubmed/34804261 http://dx.doi.org/10.1155/2021/4251763

Ejemplares similares

Immune landscape of advanced gastric cancer tumor microenvironment identifies immunotherapeutic relevant gene signature
por: Zhang, Simeng, et al.
Publicado: (2021)

Tumor Immunophenotyping‐Derived Signature Identifies Prognosis and Neoadjuvant Immunotherapeutic Responsiveness in Gastric Cancer
por: Wang, Jia‐Bin, et al.
Publicado: (2023)

Development of a Novel Immune-Related Gene Signature to Predict Prognosis and Immunotherapeutic Efficiency in Gastric Cancer
por: Liu, Dongliang, et al.
Publicado: (2022)

An immune gene signature to predict prognosis and immunotherapeutic response in lung adenocarcinoma
por: Chen, Hongquan, et al.
Publicado: (2022)

An Immune Signature for Risk Stratification and Therapeutic Prediction in Helicobacter pylori-Infected Gastric Cancer
por: Geng, Haigang, et al.
Publicado: (2022)

Immunogenomic characterization in gastric cancer identifies microenvironmental and immunotherapeutically relevant gene signatures
por: Han, Xiao, et al.
Publicado: (2021)

Colorectal Cancer Immune Infiltrates: Significance in Patient Prognosis and Immunotherapeutic Efficacy
por: Guo, Liang, et al.
Publicado: (2020)

Construction and Verification of a Hypoxia-Stemness-Based Gene Signature for Risk Stratification in Esophageal Cancer
por: Tang, Kang, et al.
Publicado: (2021)

Identification and verification of a glycolysis-related gene signature for gastric cancer
por: Liu, Yi, et al.
Publicado: (2022)

Immune signature-based risk stratification and prediction of immune checkpoint inhibitor’s efficacy for lung adenocarcinoma
por: Yi, Ming, et al.
Publicado: (2021)

Tumor Immune Microenvironment Landscape in Glioma Identifies a Prognostic and Immunotherapeutic Signature
por: Zhang, Chunyu, et al.
Publicado: (2021)

Stromal-Immune Score-Based Gene Signature: A Prognosis Stratification Tool in Gastric Cancer
por: Wang, Hao, et al.
Publicado: (2019)

Identification of Immune-Related lncRNA Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer
por: Zhang, Lianghao, et al.
Publicado: (2021)

An immune relevant signature for predicting prognoses and immunotherapeutic responses in patients with muscle‐invasive bladder cancer (MIBC)
por: Jiang, Wen, et al.
Publicado: (2020)

Immune Signature-Based Risk Stratification and Prediction of Immunotherapy Efficacy for Bladder Urothelial Carcinoma
por: Liang, Fangfang, et al.
Publicado: (2021)

Development and validation of a hypoxia-immune-based microenvironment gene signature for risk stratification in gastric cancer
por: Liu, Yifan, et al.
Publicado: (2020)

Identification and Verification of a 17 Immune-Related Gene Pair Prognostic Signature for Colon Cancer
por: Zhang, Qianshi, et al.
Publicado: (2021)

Pre-existing Immunity to Oncolytic Virus Potentiates Its Immunotherapeutic Efficacy
por: Ricca, Jacob M., et al.
Publicado: (2018)

Novel Immunotherapeutic Strategies of Gastric Cancer Treatment
por: Amedei, Amedeo, et al.
Publicado: (2011)

Development and Verification of an Immune-Related Gene Pairs Prognostic Signature in Hepatocellular Carcinoma
por: Feng, Xiaofei, et al.
Publicado: (2021)

Identification and experimental verification of an anoikis and immune related signature in prognosis for lung adenocarcinoma
por: Zhang, Jia-Le, et al.
Publicado: (2023)

Immune Landscape of Invasive Ductal Carcinoma Tumor Microenvironment Identifies a Prognostic and Immunotherapeutically Relevant Gene Signature
por: Bao, Xuanwen, et al.
Publicado: (2019)

Development and Verification of the Hypoxia- and Immune-Associated Prognostic Signature for Pancreatic Ductal Adenocarcinoma
por: Chen, Dongjie, et al.
Publicado: (2021)

Current Progress on Predictive Biomarkers for Response to Immune Checkpoint Inhibitors in Gastric Cancer: How to Maximize the Immunotherapeutic Benefit?
por: Liu, Yongqing, et al.
Publicado: (2023)

Identification of an IRGP Signature to Predict Prognosis and Immunotherapeutic Efficiency in Bladder Cancer
por: Zhang, Liang-Hao, et al.
Publicado: (2021)

Exploring immune-related signatures for predicting immunotherapeutic responsiveness, prognosis, and diagnosis of patients with colon cancer
por: Cao, Lichao, et al.
Publicado: (2022)

An Immunosenescence-Related Gene Signature to Evaluate the Prognosis, Immunotherapeutic Response, and Cisplatin Sensitivity of Bladder Cancer
por: Zhou, Ranran, et al.
Publicado: (2022)

Discovery of novel immunotherapeutic drug candidates for sciatic nerve injury using bioinformatic analysis and experimental verification
por: Li, Shengyou, et al.
Publicado: (2022)

Immune Infiltration-Related Signature Predicts Risk Stratification and Immunotherapy Efficacy in Grade II and III Gliomas
por: Luo, Cong, et al.
Publicado: (2021)

Tumor Microenvironment Profiling Identifies Prognostic Signatures and Suggests Immunotherapeutic Benefits in Neuroblastoma
por: Feng, Chenzhao, et al.
Publicado: (2022)

P1247: IDENTIFICATION AND VERIFICATION OF IMMUNE-RELATED GENE PROGNOSTIC SIGNATURE BASED ON SSGSEA FOR DLBCL
por: Shi, Wenyu
Publicado: (2023)

Metabolism-Related Signature Analysis Uncovers the Prognostic and Immunotherapeutic Characteristics of Renal Cell Carcinoma
por: Zhang, Jianye, et al.
Publicado: (2022)

Identification and Validation of a m5C RNA Modification-Related Gene Signature for Predicting Prognosis and Immunotherapeutic Efficiency of Gastric Cancer
por: Song, Li, et al.
Publicado: (2023)

Identification and verification of an ALYREF-involved 5-methylcytosine based signature for stratification of prostate cancer patients and prediction of clinical outcome and response to therapies
por: Tan, Xiao, et al.
Publicado: (2023)

Nanomedicines targeting activation of STING to reshape tumor immune microenvironment and enhance immunotherapeutic efficacy
por: Chen, Shanshan, et al.
Publicado: (2023)

Novel immune‐related signature for risk stratification and prognosis in prostatic adenocarcinoma
por: Zhao, Hai‐Bo, et al.
Publicado: (2021)

Establishment of an Immune-Related Gene Signature for Risk Stratification for Patients with Glioma
por: He, Jimin, et al.
Publicado: (2021)

Ferroptosis Characterization in Lung Adenocarcinomas Reveals Prognostic Signature With Immunotherapeutic Implication
por: Sun, Sijin, et al.
Publicado: (2021)

Immunogenomic Landscape in Breast Cancer Reveals Immunotherapeutically Relevant Gene Signatures
por: Wang, Tao, et al.
Publicado: (2022)

Immunotherapeutic Significance of a Prognostic Alternative Splicing Signature in Bladder Cancer
por: Chen, Jiang, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dcql4jjldhil7tqil12it9vr04